Algert Global’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361K | Sell |
32,185
-96,730
| -75% | -$1.08M | 0.01% | 1000 |
|
|
2025
Q1 | $589K | Sell |
128,915
-59,090
| -31% | -$270K | 0.01% | 873 |
|
|
2024
Q4 | $1.06M | Sell |
188,005
-36,211
| -16% | -$204K | 0.02% | 772 |
|
|
2024
Q3 | $1.09M | Buy |
224,216
+86,720
| +63% | +$420K | 0.03% | 733 |
|
|
2024
Q2 | $671K | Buy |
+137,496
| New | +$671K | 0.02% | 795 |
|
|
2024
Q1 | – | Sell |
-10,452
| Closed | -$146K | – | 1284 |
|
|
2023
Q4 | $146K | Sell |
10,452
-7,570
| -42% | -$106K | 0.01% | 1046 |
|
|
2023
Q3 | $239K | Hold |
18,022
| – | – | 0.01% | 932 |
|
|
2023
Q2 | $338K | Buy |
18,022
+7,390
| +70% | +$139K | 0.01% | 887 |
|
|
2023
Q1 | $153K | Sell |
10,632
-5,538
| -34% | -$79.7K | 0.01% | 1047 |
|
|
2022
Q4 | $313K | Buy |
+16,170
| New | +$313K | 0.02% | 926 |
|